| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year complete | Primary publication | Full study treatment protocol/patient disposition |
|---|---|---|---|---|---|
|
ATLANTIC (Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial) |
50 | Bayer (NCT02495181) | 2019 | Silva R, et al. Ophthalmologica. 2022;245:80-90. https://www.karger.com/Article/FullText/518235 |
|